Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Mizumoto K; Chowell G
  • Source:
    Emerging infectious diseases [Emerg Infect Dis] 2020 Jun; Vol. 26 (6), pp. 1251-1256. Date of Electronic Publication: 2020 Jun 17.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
    • Publication Information:
      Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-
    • Subject Terms:
    • Abstract:
      Since December 2019, when the first case of coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and ≈1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control.
    • References:
      Am J Epidemiol. 2013 Apr 15;177(8):834-40. (PMID: 23459950)
      N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
      Int J Infect Dis. 2015 Oct;39:7-9. (PMID: 26275845)
      J Theor Biol. 2003 Sep 7;224(1):1-8. (PMID: 12900200)
      Am J Epidemiol. 2005 Sep 1;162(5):479-86. (PMID: 16076827)
      PLoS Med. 2009 Dec;6(12):e1000207. (PMID: 19997612)
      BMC Med. 2015 Sep 03;13:210. (PMID: 26336062)
      BMJ. 2009 Jul 14;339:b2840. (PMID: 19602714)
      J Infect. 2020 Apr;80(4):401-406. (PMID: 32112886)
      Lancet. 2014 Oct 4;384(9950):1260. (PMID: 25260235)
      Infect Dis Model. 2020 Feb 29;5:264-270. (PMID: 32190785)
      Theor Biol Med Model. 2019 Oct 7;16(1):16. (PMID: 31587665)
      N Engl J Med. 2020 Mar 5;382(10):970-971. (PMID: 32003551)
      BMC Med. 2015 Sep 30;13:228. (PMID: 26420593)
      PLoS One. 2009 Aug 31;4(8):e6852. (PMID: 19718434)
      J Med Virol. 2020 Feb 28;:. (PMID: 32108351)
      Euro Surveill. 2017 Nov;22(46):. (PMID: 29162211)
      Stat Med. 2007 Apr 30;26(9):1982-98. (PMID: 16981181)
      Euro Surveill. 2020 Mar;25(10):. (PMID: 32183930)
    • Contributed Indexing:
      Keywords: 2019 novel coronavirus disease; CFR; COVID-19; China; Hubei; SARS-CoV-2; Wuhan; case-fatality ratio; coronavirus; death; mortality; outbreak; respiratory diseases; risk; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses
    • Publication Date:
      Date Created: 20200314 Date Completed: 20200527 Latest Revision: 20201218
    • Publication Date:
      20240105
    • Accession Number:
      PMC7258458
    • Accession Number:
      10.3201/eid2606.200233
    • Accession Number:
      32168464